Shingrix
Shingrix demand may have reached its peak
Initial demand for the Shingrix vaccine has been “much higher” than the Department of Health and Aged Care has seen for other jabs on the NIP an official says More …
NIPVIP payments to be indexed to MBS
Government to invest $631.1 million to support access to vaccination services Fees paid to pharmacists for administering vaccinations through the National Immunisation Program (NIP) will be indexed in line with …
GSK to bolster Shingrix supply
TGA grants temporary approval for the use of overseas-sourced Shingrix in Australia GSK is set to supply Shingrix vaccines registered in Hong Kong to the Australian market for patients eligible …
State’s Shingrix supply runs dry
Pharmacists advised to prioritise “highest risk patients” for Shingrix vaccines, as state’s NIP supply “exhausted” NSW Health is reporting that its allocation of the Shingrix vaccine through the National Immunisation …
High demand puts pressure on Shingrix supply chain
GSK expects to deliver 1.1 million doses of its shingles vaccine to the Commonwealth in the first half of 2024 Higher than anticipated demand for the National Immunisation Program (NIP) …
Pharmacies claim over $227k through NIPVIP in January
Pharmacists deliver more than 12,000 jabs through the NIPVIP in the program’s first month Close to half of Australia’s Section 90 approved community pharmacies are registered to participate in the …
Legislative changes needed for Shingrix
New legislation needed to enable pharmacists to provide Shingrix shots in four jurisdictions Plans to roll out free shingles vaccines to patients aged 65 years and older through community pharmacies …
Shingles needs a shake-up
A campaign aims to make Australians shingles-aware — and one group says pharmacists could help. A new campaign has been launched to raise awareness of the signs, symptoms and risk …